EDGAR Filing Documents for 9999999995-23-002993

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-23-002993

Accepted

2023-10-17 00:15:22

Documents

Effectiveness Date

2023-10-16

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	588
	Complete submission text file	9999999995-23-002993.txt		1724

Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5

Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)